We selected p53 wild-type IMR-5 (expressing high CBR1 and low CRB2) and p53 mutant SK-N-AS (expressing low CBR1 and high CBR2) neuroblastoma cell lines as a model system. This evidence concerns the gene CRB2 and neuroblastoma.